Document Detail


Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.
MedLine Citation:
PMID:  22863724     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The median survival of women with metastatic breast cancer (MBC) is 18-24 months, and fewer than 5% are alive and disease free at 5 years. We report toxicity and survival in a cohort of MBC patients receiving high-dose chemotherapy (HDC) with autologous hematopoietic SCT (AHSCT) in Italy between 1990 and 2005. Data set for survival analysis has been obtained for 415 patients. Clinical parameters including probability of transplant-related mortality (TRM), PFS and OS. With a median follow-up of 27 months (range 0-172), OS and PFS at 5 and 10 years in the whole population were 47/23 and 32/14%, respectively. A total 239 patients are alive with a median follow-up of 33 months (range 2-174). Survival was significantly more pronounced in patients harboring hormone receptor positive tumors (P=0.028), without visceral metastases (P=0.009) and in women with chemosensitive disease (P<0.0001). Sixty eight patients (20.4%) who received HDC in partial response, stable or progressive disease underwent conversion to CR. TRM was 2.5% overall and 1.3% since 2000. Our findings suggest that could be a role for HDC and AHSCT in delaying disease progression and possibly cure a subset of MBC patient harboring chemosensitive tumors.Bone Marrow Transplantation advance online publication, 6 August 2012; doi:10.1038/bmt.2012.149.
Authors:
M Martino; A Ballestrero; A Zambelli; S Secondino; M Aieta; C Bengala; A M Liberati; C Zamagni; M Musso; M Aglietta; R Schiavo; L Castagna; G Rosti; B Bruno; P Pedrazzoli
Related Documents :
22356324 - Survival in braf v600-mutant advanced melanoma treated with vemurafenib.
22420964 - Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity...
22289524 - Treatment of borrmann type iv gastric cancer with a neoadjuvant chemotherapy combinatio...
22840974 - Does the presence of adenomyosis and lymphovascular space invasion affect lymph node st...
18166314 - Prenatal prognosis in isolated congenital diaphragmatic hernia.
7705704 - Treatment of locally advanced cervical cancer with concurrent radiation and intra-arter...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-06
Journal Detail:
Title:  Bone marrow transplantation     Volume:  -     ISSN:  1476-5365     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera BMM, Reggio Calabria, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelate...
Next Document:  More than skin deep? Emerging therapies for chronic cutaneous GVHD.